Catalyst Wire Dossier Catalyst Wire Dossier

DWP16001 (in combination with metformin)

DWP16001 · Daewoong Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWP16001 (in combination with metformin), covering 2024-04-04 to 2024-04-04. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin [Phase 3]

See pricing